Nature Communications · 2017 · 29 citations · 48 references
Veterinary MedicineCell BiologyOncologyCarcinogenesisMolecular OncologyNeoplasiaKidney CancerMalignant NeoplasmsMalignant TumorsNeoplastic TransformationRenal NeoplasmsTumor DifferentiationBiallelic InactivationKnockout Mouse ModelsMtor InhibitionRenal AngiomyolipomaRenal Epithelial DifferentiationRenal MalignancyRenal Tubule DifferentiationTsc1 Mutations
Renal angiomyolipomas (AML) contain an admixture of clonal tumour cells with features of several different mesenchymal lineages, implying the existence of an unidentified AML neoplastic stem cell. Biallelic inactivation of TSC2 or TSC1 is believed to represent the driving event in these tumours. Here we show that TSC2 knockdown transforms senescence-resistant cultured mouse and human renal epithelial cells into neoplastic stem cells that serially propagate renal AML-like tumours in mice. mTOR inhibitory therapy of mouse AML allografts mimics the clinical responses of human renal AMLs. Deletion of Tsc1 in mouse renal epithelia causes differentiation in vivo into cells expressing characteristic AML markers. Human renal AML and a renal AML cell line express proximal tubule markers. We describe the first mouse models of renal AML and provide evidence that these mesenchymal tumours originate from renal proximal tubule epithelial cells, uncovering an unexpected pathological differentiation plasticity of the proximal tubule.
48
John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · The Lancet · 2013 · 879 citations
Costanza Sagrinati, Giuseppe Stefano Netti, Benedetta Mazzinghi et al. · Journal of the American Society of Nephrology · 2006 · 733 citations
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Paul Krimpenfort, Kim Quon, Wolter J. Mooi et al. · Nature · 2001 · 588 citations